Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,328.00
Bid: 1,342.00
Ask: 1,345.00
Change: 3.00 (0.23%)
Spread: 3.00 (0.224%)
Open: 1,319.00
High: 1,380.00
Low: 1,311.00
Prev. Close: 1,325.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Gain After Powell Remarks; Indivior Surges

Thu, 11th Jul 2019 08:36

(Alliance News) - London stocks on Thursday started the second day of US Federal Reserve Chair Jerome Powell's testimony to Congress in positive territory after dovish remarks made on Wednesday.Reckitt Benckiser was among the stocks pushing the FTSE 100 higher after agreeing to settle a US probe for USD1.4 billion, while former subsidiary Indivior surged on boosted guidance.The large-cap index was 19.88 points higher, or 0.3%, at 7,550.57 early Thursday. The mid-cap FTSE 250 index was up 77.01 points, or 0.4%, at 19,496.39, while the AIM All-Share was flat at 914.43.The Cboe UK 100 index was up 0.2% at 12,800.40. The Cboe UK 250 was 0.3% higher at 17,387.03, while the Cboe UK Small Companies was up 0.7% at 11,313.55.In mainland Europe, the CAC 40 index in Paris and DAX 30 in Frankfurt were up 0.3% and 0.2% respectively in early trade.Stocks in Europe started Thursday's session on the front foot after dovish remarks from US Federal Reserve Chair Jerome Powell. In comments welcomed by Wall Street, Powell said many central bankers believed the case for lower rates "had strengthened" last month given the rising "crosscurrents" in the economy.In his highly anticipated testimony to Congress, Powell repeatedly stressed the importance of keeping the US economy growing to ensure its benefits reach Americans left at the margins and said the central bank will deploy all its tools to support continued expansion."Willingness to cut the [federal funds rate] removed the latest concerns of the most cautious market participants and launched a new round of rally, affecting a wide range of instruments - from the dollar and stock indexes to commodities," said analysts at FxPro.This positive sentiment in stock markets flowed through to Asia on Thursday, with the Japanese Nikkei 225 index ending up 0.5%. In China, the Shanghai Composite closed up 0.1%, while the Hang Seng index in Hong Kong is 0.7% higher in late trade.The day ahead has US inflation readings at 1330 BST. In addition, the Bank of England will release its financial stability report at 1030 BST, the European Central Bank releases accounts from its last monetary policy meeting at 1230 BST and Powell returns to Congress at 1500 BST. Already released, German inflation accelerated in June, as initially estimated, on higher package holiday prices.The consumer price index rose 1.6% year-on-year in June, reaffirming the provisional reading and faster than the 1.4% rise recorded for May. Month-on-month, consumer prices were up 0.3%, again in line with the flash reading.The higher inflation rate in June was caused by package holidays, Destatis said, with prices up 6.1% in June after a 9.0% fall in May. This helped to offset energy product prices rising just 2.5% in June, slowing from a 4.2% rise in May.In London, Reckitt was up 2.3% after agreeing to pay up to USD1.4 billion to resolve an investigation into the sales and marketing of Suboxone Film.Suboxone Film contains buprenorphine, a controlled substance that is used an an opioid replacement for addicts.The agreement has been reached with the US Department of Justice and the Federal Trade Commission. Suboxone Film is a product owned by Indivior, Reckitt's former prescription pharmaceuticals business which was demerged from the Reckitt group in 2014. Indivior now is separately listed on the London Stock Exchange.The payment will fully resolve all federal investigations into Reckitt in connection to Indivior's indictment and claims relating to state Medicaid programs for those states choosing to participate in the settlement."While RB has acted lawfully at all times and expressly denies all allegations that it engaged in any wrongful conduct, after careful consideration, the board of RB determined that the agreement is in the best interests of the company and its shareholders," said Reckitt.The company continued: "It avoids the costs, uncertainty and distraction associated with continued investigations, litigation and the potential for an indictment at a time of significant transformation under RB 2.0 and during CEO transition."Nurofen painkiller maker Reckitt currently has a provision of USD400 million which it will increase to USD1.5 billion at its half-year results.Separately, Indivior on Thursday raised its guidance following a stronger than expected first half.Indivior - which did not mention the Reckitt announcement in its own on Thursday - now expects net revenue in a range of USD670 million to USD720 million, a sharp increase from previous forecasts of USD525 million to USD575 million. Net income is expected between USD80 million to USD130 million. Prior to this, the company had anticipated anything from a loss of USD40 million to income of USD10 million.The primary driver has been a market share outperformance from Suboxone Film, the company explained. Indivior shot up 23% in early dealings.Credit checking firm Experian was towards the bottom of the FTSE 100 index, down 1.3% after Goldman Sachs cut the stock to Neutral from Buy.FTSE 250 technical products and services firm Diploma was up 2.8% after agreeing the GBP56.0 million takeover of a gasket and fluid-sealing products maker.Virginia Sealing Products specialises in customers who process and transport hazardous materials but also operates in markets such as power generation, pulp & paper, and marine. Diploma is paying GBP56.0 million in cash upfront, but it may also pay a further GBP8.0 million if VSP meets various operating profit targets. The deal will be funded from existing cash and new debt, but Diploma said it "will continue to maintain a strong balance sheet".

More News
22 Feb 2024 11:44

LONDON MARKET MIDDAY: Stocks boosted as UK recession "already" over

(Alliance News) - Stock prices in London were higher at midday Thursday, with the latest UK purchasing managers' index data indicating that the UK recession is "already" over.

Read more
22 Feb 2024 09:55

TOP NEWS: Indivior swings to profit as eyes primary listing move to US

(Alliance News) - Shares in Indivior PLC rose on Thursday, after the company said that strong sales of its flagship Sublocade treatment had pushed its revenue to new heights, and it added that it will begin talks with shareholders to move its primary listing across the Atlantic.

Read more
22 Feb 2024 08:26

Indivior planning to move primary listing to US, shares surge

(Sharecast News) - Indivior surged on Thursday after the opioid addiction treatment maker said it was planning to move its primary listing to the US.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
20 Dec 2023 15:05

London close: Stocks rise as UK inflation slows further

(Sharecast News) - London's stock markets saw a notable upswing on Wednesday, driven by encouraging data revealing a greater-than-anticipated slowdown in UK inflation for November.

Read more
20 Dec 2023 11:56

LONDON MARKET MIDDAY: Stocks sparkle thanks to UK inflation data

(Alliance News) - Stock prices in London were higher at midday Wednesday, as investors felt the festive cheer thanks to cooler-than-expected inflation data for the UK.

Read more
20 Dec 2023 10:59

IN BRIEF: Indivior agrees settlement with Actavis over patent dispute

Indivior PLC - Richmond, Virginia-based pharmaceutical firm - Says its subsidiaries Indivior Inc and Indivior UK Ltd has agreed on a settlement deal with Actavis Laboratories UT Inc, a subsidiary of Teva Pharmaceuticals, resolving patent disputes of Actavis's abbreviated new drug application for generic buprenorphine and naloxone sublingual film. Says it has granted Actavis a license to US patent no.11,135,216, allowing it to launch general film products in the US from January 31 2025, unless unexpired patent claims are found to be invalid.

Read more
20 Dec 2023 08:48

LONDON MARKET OPEN: Stocks feeling festive on UK, US rate cut hopes

(Alliance News) - Stock in London enjoyed a broad-based rally at Wednesday's open, as a surprise UK inflation print boosted risk sentiment, with investors pinning their hopes on UK and US interest rate cuts next year.

Read more
20 Dec 2023 07:26

Indivior strikes agreement with Actavis over patent dispute

(Sharecast News) - Indivior announced significant agreement in its ongoing patent dispute with Actavis Laboratories UT, a subsidiary of Teva Pharmaceuticals, on Wednesday.

Read more
5 Dec 2023 15:38

Indivior and Reckitt land legal boost in UK Suboxone claim

(Alliance News) - Indivior PLC and one-time parent Reckitt Benckiser Group PLC were handed a legal victory on Tuesday after the High Court of Justice of England & Wales dismissed a lawsuit related to alleged false marketing of an opioid addiction treatment.

Read more
24 Nov 2023 09:23

LONDON BROKER RATINGS: Investors told to 'sell' Sage and Deliveroo

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
20 Nov 2023 14:59

London close: Stocks mixed ahead of Autumn Statement

(Sharecast News) - London's stock markets saw a mixed performance at the close of trading on Monday, with Ashtead and Compass among the leading losers.

Read more
17 Nov 2023 12:15

Indivior announces $100m share buyback

(Sharecast News) - Pharma group Indivior has announced a $100m share buyback to reduce its issued shared capital and return cash to shareholders.

Read more
17 Nov 2023 12:08

UPDATE: Indivior plans up to USD100 million share buyback programme

(Alliance News) - Indivior PLC on Friday announced a new share buyback programme, as it hailed its outlook for medium-term profitable growth.

Read more
17 Nov 2023 09:46

Indivior to keep Scopia's Jerome Lande on board as agreement extended

(Alliance News) - Indivior PLC on Friday said it changed its existing relationship with Scopia Capital Management LP to keep Scopia representative Jerome Lande on the Indivior board.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.